Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

MRTX Mirati Therapeutics Inc

58,70

0,00 (0,00%)

22 Nov 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

null

Mirati Therapeutics (NASDAQ:MRTX)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more Mirati Therapeutics Charts.

Mirati Therapeutics (NASDAQ:MRTX)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more Mirati Therapeutics Charts.

News Mirati Therapeutics Inc

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (9 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (9 Monate vor) • Edgar (US Regulatory)

Form 15-12G - Securities registration termination [Section 12(g)]
Freitag 2 Februar 2024 (10 Monate vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Donnerstag 25 Januar 2024 (10 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 24 Januar 2024 (10 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 24 Januar 2024 (10 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 24 Januar 2024 (10 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 24 Januar 2024 (10 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 24 Januar 2024 (10 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 24 Januar 2024 (10 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 24 Januar 2024 (10 Monate vor) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Dienstag 23 Januar 2024 (10 Monate vor) • Edgar (US Regulatory)

Weitere Mirati Therapeutics Inc News-Artikel

Jpm Egb13 Ucits

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen